| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a method for treating Alzheimer's disease by administering rhamnolipids as an active ingredient of therapeutic agents. <P>SOLUTION: A pharmaceutical composition for treating Alzheimer's disease, containing one or more rhamnolipids represented by formula (1) [wherein, R<SP>1</SP>is H orα-L-rhamnopyranosyl; R<SP>2</SP>is H or -CH(R<SP>4</SP>)-CH<SB>2</SB>-COOH; R<SP>3</SP>is a 5-20C saturated, mono or polyunsaturated hydrocarbyl; and R<SP>4</SP>is a 5-20C saturated, mono or polyunsaturated hydrocarbyl] as an active ingredient is provided. <P>COPYRIGHT: (C)2008,JPO&INPIT</p> |
